Lara Buscemi

Dr. Lara Buscemi


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2003 in Biophysical Journal
Verified
Journal Article
Closed access
JAJordi Alcaraz
Jordi Alcaraz
LBLara Buscemi
Lara Buscemi
MGMireia Grabulosa
Mireia Grabulosa
XTXavier Trepat
Xavier Trepat
BFBen Fabry
Ben Fabry
DNDaniel Navajas
Daniel Navajas

1 July 2014 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
VAVolker F. Achterberg
Volker F. Achterberg
LBLara Buscemi
Lara Buscemi
HDHeike Diekmann
Heike Diekmann
JSJosiane Smith-Clerc
Josiane Smith-Clerc
HSHelge Schwengler
Helge Schwengler
BHBoris Hinz
Boris Hinz

20 October 2014 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
FKFranco Klingberg
Franco Klingberg
MCMelissa L. Chow
Melissa L. Chow
AKAnne Koehler
Anne Koehler
SBStellar Boo
Stellar Boo
LBLara Buscemi
Lara Buscemi
BHBoris Hinz
Boris Hinz
Integrin-mediated force application induces a conformational change in latent TGF-β1 that leads to the release of the active form of the growth factor from the extracellular matrix (ECM). Mechanical activation of TGF-β1 is currently understood as an acute process that depends on the contractile force of cells. However, we show that ECM remodeling, preceding the activation step, mechanically primes latent TGF-β1 akin to loading a mechanical spring. Cell-based assays and unique strain devices were used to produce a cell-derived ECM of controlled organization and prestrain. Mechanically conditioned ECM served as a substrate to measure the efficacy of TGF-β1 activation after cell contraction or direct force application using magnetic microbeads. The release of active TGF-β1 was always higher from prestrained ECM as compared with unorganized and/or relaxed ECM. The finding that ECM prestrain regulates the bioavailability of TGF-β1 is important to understand the context of diseases that involve excessive ECM remodeling, such as fibrosis or cancer.

1 December 2011 in Current Biology
Verified
Journal Article
Closed access
LBLara Buscemi
Lara Buscemi
DRDavid Ramonet
David Ramonet
FKFranco Klingberg
Franco Klingberg
AFAurélie Formey
Aurélie Formey
JSJosiane Smith-Clerc
Josiane Smith-Clerc
BHBoris Hinz
Boris Hinz

10 January 2002 in Langmuir
Verified
Journal Article
Closed access
JAJordi Alcaraz
Jordi Alcaraz
LBLara Buscemi
Lara Buscemi
MPM. Puig-De-Morales
M. Puig-De-Morales
JCJaime Colchero
Jaime Colchero
ABA. Baró
A. Baró
DNDaniel Navajas
Daniel Navajas

1 March 2009 in Biomaterials
Verified
Journal Article
Closed access
PWPierre-Jean Wipff
Pierre-Jean Wipff
HMHicham Majd
Hicham Majd
CAChitrangada Acharya
Chitrangada Acharya
LBLara Buscemi
Lara Buscemi
JMJean-Jacques Meister
Jean-Jacques Meister
BHBoris Hinz
Boris Hinz